India deserves its own entry not because the rules are complicated — quite the opposite. India's vape rules are extremely simple: full prohibition, no exceptions. But India's traditional cigarette market is enormous (roughly 106 million adult smokers), and that contrast — a tempting market size paired with zero legal entry — is a risk that's often underweighted in sourcing decisions.
The core rule: banned across the entire chain, from production to advertising
Since 2019, India's e-cigarette ban legislation (PECA, covering production, manufacture, import, export, transport, sale, distribution, storage, and advertisement) has made every stage of the vaping category illegal:
- Production and manufacture
- Import and export
- Transport and storage
- Sale and distribution
- Advertising
This scope is more comprehensive than most "full ban" markets — it's not just "no retail sale," even stockpiling on someone else's behalf falls within the prohibited scope.
Penalties
- First offense: up to 1 year imprisonment, a fine of 100,000 rupees (about $1,405)
- Repeat offense: up to 3 years imprisonment, fines up to 500,000 rupees
Worth noting: this penalty framework explicitly distinguishes between traditional tobacco companies and vaping companies — traditional cigarettes remain legal to sell, but vape startups (Juul was named specifically at the time the ban took effect) are shut out of the market entirely. In other words, India's policy logic isn't "opposed to nicotine" broadly — it's specifically targeted at the vaping product category.
An easily overlooked backdrop: the scale of India's public health data
WHO data shows tobacco use (smoked and smokeless combined) kills close to 1 million people annually in India — a scale that helps explain the regulator's hardline stance on vaping: facing an already-massive traditional tobacco problem, regulatory energy has leaned toward "don't introduce a new nicotine product category" rather than "assess whether vaping is less harmful than traditional cigarettes." This policy philosophy aligns with South Africa's Department of Health stance covered elsewhere on this site (explicitly rejecting harm-reduction framing).
Practical guidance for distributors
- India currently offers no compliant operating pathway — the ban has shown no signs of easing since taking effect in 2019; recommend excluding it from channel planning entirely
- Don't let the "100+ million smokers" figure tempt an evaluation of grey-market opportunity — India's penalty framework covers the entire chain from production to advertising, and the risk and potential losses of participating in a grey channel are disproportionate to the market's apparent size
- India's traditional cigarette and tobacco product market remains legal and substantial — if your supply chain includes those product lines (outside the vaping category itself), that follows an entirely different compliance path, unaffected by the ban discussed here
(General information only, not legal advice — consult a lawyer familiar with Indian compliance before making business decisions.)